ClearBridge Investments’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-1,463,262
| Closed | -$9.2M | – | 1124 |
|
|
2019
Q2 | $9.2M | Buy |
1,463,262
+171,132
| +13% | +$1.08M | 0.01% | 539 |
|
|
2019
Q1 | $7.18M | Buy |
1,292,130
+42,540
| +3% | +$237K | 0.01% | 554 |
|
|
2018
Q4 | $8.3M | Sell |
1,249,590
-46,320
| -4% | -$308K | 0.01% | 547 |
|
|
2018
Q3 | $13.8M | Buy |
1,295,910
+1,295,777
| +974,268% | +$13.8M | 0.01% | 503 |
|
|
2018
Q2 | $2K | Buy |
133
+11
| +9% | +$165 | ﹤0.01% | 1095 |
|
|
2018
Q1 | $1K | Hold |
122
| – | – | ﹤0.01% | 1139 |
|
|
2017
Q4 | $1K | Sell |
122
-2,432
| -95% | -$19.9K | ﹤0.01% | 1148 |
|
|
2017
Q3 | $31K | Buy |
2,554
+305
| +14% | +$3.7K | ﹤0.01% | 968 |
|
|
2017
Q2 | $37K | Buy |
2,249
+412
| +22% | +$6.78K | ﹤0.01% | 903 |
|
|
2017
Q1 | $26K | Buy |
+1,837
| New | +$26K | ﹤0.01% | 970 |
|